The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Diabetic peripheral neuropathy: Current perspective and future directions
Abstract
Diabetic neuropathy is a heterogeneous group of disorders with extremely complex pathophysiology and affects both somatic and autonomic components of the nervous system. Neuropathy is the most common chronic complication of diabetes mellitus. Metabolic disruptions in the peripheral nervous system, including altered protein kinase C activity, and increased polyol pathway activity in neurons and Schwann cells resulting from hyperglycemia plays a key role in the development of diabetic neuropathy. These pathways are related to the metabolic and/or redox state of the cell and are the major source of damage. Activation of these metabolic pathways leads to oxidative stress, which is a mediator of hyperglycemia induced cell injury and a unifying theme for all mechanisms of diabetic neuropathy. The therapeutic intervention of these metabolic pathways is capable of ameliorating diabetic neuropathy but therapeutics which target one particular mechanism may have a limited success. Available therapeutic approaches are based upon the agents that modulate pathogenetic mechanisms (glycemic control) and relieve the symptoms of diabetic neuropathy. This review emphasizes the pathogenesis, presently available therapeutic approaches and future directions for the management of diabetic neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452 · Cited by 237
RetractedGabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J., & Moore, R. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452.pub2 · Cited by 230
RetractedReceptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy
Toth, C., Rong, L. L., Yang, C., Martinez, J., Song, F., Ramji, N., Brussee, V., Liu, W., Durand, J., Nguyen, M. D., et al. (2008) · Diabetes · doi:10.2337/db07-0339 · Cited by 187
RetractedDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Backonja, M. (1998) · JAMA · doi:10.1001/jama.280.21.1831 · Cited by 1,533
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
Max, M. B., Lynch, S. A., Muir, J., Shoaf, S. E., Smoller, B., & Dubner, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261904 · Cited by 1,117
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Weaver, D. F., & Houlden, R. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042580 · Cited by 1,091
Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
Johansen, J. S., Harris, A. K., Rychly, D. J., & Ergul, A. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-5 · Cited by 1,003
Duloxetine vs. placebo in patients with painful diabetic neuropathy
Goldstein, D. J., Lu, Y., Detke, M. J., Lee, T. C., & Iyengar, S. (2005) · Pain · doi:10.1016/j.pain.2005.03.029 · Cited by 858
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2005) · Diabetes Care · doi:10.2337/diacare.28.suppl_1.s37 · Cited by 830
Sima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Schmidt, A. M., Yan, S. D., Wautier, J.-L., & Stern, D. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 791
Diabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Antidepressants for neuropathic pain
Saarto, T., & Wiffen, P. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005454.pub2 · Cited by 764
The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Rosenstock, J., Tuchman, M., LaMoreaux, L., & Sharma, U. (2004) · Pain · doi:10.1016/j.pain.2004.05.001 · Cited by 725
Williams Textbook of Endocrinology
Reutrakul, S. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000323673.44568.e8 · Cited by 711
Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood
Max, M. B., Culnane, M., Schafer, S. C., Gracely, R. H., Walther, D. J., Smoller, B., & Dubner, R. (1987) · Neurology · doi:10.1212/wnl.37.4.589 · Cited by 702
Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study
Rice, A. S. C., & Maton, S. (2001) · Pain · doi:10.1016/s0304-3959(01)00407-9 · Cited by 596
Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial
Lesser, H., Sharma, U., LaMoreaux, L., & Poole, R. M. (2004) · Neurology · doi:10.1212/01.wnl.0000145767.36287.a1 · Cited by 570
Double‐blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy
Harati, Y., Gooch, C., Swenson, M., Edelman, S., Greene, D., Raskin, P., Donofrio, P., Cornblath, D., Sachdeo, R., Siu, C. O., et al. (1998) · Neurology · doi:10.1212/wnl.50.6.1842 · Cited by 546
Raskin, J., Pritchett, Y. L., Wang, F., D'Souza, D. N., Waninger, A. L., Iyengar, S., & Wernicke, J. F. (2005) · Pain Medicine · doi:10.1111/j.1526-4637.2005.00061.x · Cited by 532
The Role of Oxidative Stress in Diabetic Complications
Niedowicz, D. M., & Daleke, D. L. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:2:289 · Cited by 524
Rowbotham, M. C., Goli, V., Kunz, N. R., & Lei, D. (2004) · Pain · doi:10.1016/j.pain.2004.05.010 · Cited by 521
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain
Wernicke, J. F., Pritchett, Y. L., D’Souza, D. N., Waninger, A., Tran, P., Iyengar, S., & Raskin, J. (2006) · Neurology · doi:10.1212/01.wnl.0000240225.04000.1a · Cited by 510
Watson, P. C. N., Moulin, D., Watt-Watson, J., Gordon, A., & Eisenhoffer, J. (2003) · Pain · doi:10.1016/s0304-3959(03)00160-x · Cited by 510
Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Jackson, A. C., & Houlden, R. L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61081-3 · Cited by 500
The role of protein kinase C activation and the vascular complications of diabetes
DASEVCIMEN, N., & KING, G. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.04.016 · Cited by 494
Vinik, A. I., Park, T. S., Stansberry, K. B., & Pittenger, G. L. (2000) · Diabetologia · doi:10.1007/s001250051477 · Cited by 489
Hyperglycemia-induced oxidative stress in diabetic complications
King, G. L., & Loeken, M. R. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0678-9 · Cited by 488
Richter, R. W., Portenoy, R., Sharma, U., Lamoreaux, L., Bockbrader, H., & Knapp, L. E. (2005) · The Journal of Pain · doi:10.1016/j.jpain.2004.12.007 · Cited by 473
Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial
Gimbel, J. S., Richards, P., & Portenoy, R. K. (2003) · Neurology · doi:10.1212/01.wnl.0000057720.36503.2c · Cited by 469
Sindrup, S. H., Gram, L. F., Brøsen, K., Eshøj, O., & Mogensen, E. F. (1990) · Pain · doi:10.1016/0304-3959(90)91157-e · Cited by 463
Morello, C. M., Leckband, S. G., Stoner, C. P., Moorhouse, D. F., & Sahagian, G. A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1931 · Cited by 445
Errington, A. C., Stöhr, T., Heers, C., & Lees, G. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039867 · Cited by 435
Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial
Serpell, M. G. (2002) · Pain · doi:10.1016/s0304-3959(02)00255-5 · Cited by 433
Kolm-Litty, V, Sauer, U., Nerlich, A., Lehmann, R., & Schleicher, E. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119875 · Cited by 430
Ziegler, D., Low, P. A., Litchy, W. J., Boulton, A. J. M., Vinik, A. I., Freeman, R., Samigullin, R., Tritschler, H., Munzel, U., Maus, J., et al. (2011) · Diabetes Care · doi:10.2337/dc11-0503 · Cited by 401
Free radicals in diabetic endothelial cell dysfunction
Tesfamariam, B. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90040-x · Cited by 398
Tzschentke, T. M., Christoph, T., Kögel, B., Schiene, K., Hennies, H.-H., Englberger, W., Haurand, M., Jahnel, U., Cremers, T. I. F. H., Friderichs, E., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.126052 · Cited by 395
Painful Diabetic Neuropathy: Epidemiology, Natural History, Early Diagnosis, and Treatment Options
Veves, A., Backonja, M., & Malik, R. A. (2008) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00347.x · Cited by 375
Hotta, N., Akanuma, Y., Kawamori, R., Matsuoka, K., Oka, Y., Shichiri, M., Toyota, T., Nakashima, M., Yoshimura, I., Sakamoto, N., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2370 · Cited by 366
Antidepressants and Anticonvulsants for Diabetic Neuropathy and Postherpetic Neuralgia
Collins, S. L., Moore, R. A., McQuay, H. J., & Wiffen, P. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00218-9 · Cited by 351
Kaneto, H., Xu, G., Song, K.-H., Suzuma, K., Bonner-Weir, S., Sharma, A., & Weir, G. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104115200 · Cited by 327
Polyol pathway and diabetic peripheral neuropathy
Oates, P. J. (2002) · International Review of Neurobiology · doi:10.1016/s0074-7742(02)50082-9 · Cited by 322
Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic Patients
Judzewitsch, R. G., Jaspan, J. B., Polonsky, K. S., Weinberg, C. R., Halter, J. B., Halar, E., Pfeifer, M. A., Vukadinovic, C., Bernstein, L., Schneider, M., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301203080302 · Cited by 313
Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study
Eisenberg, E., Lurie, Y., Braker, C., Daoud, D., & Ishay, A. (2001) · Neurology · doi:10.1212/wnl.57.3.505 · Cited by 301
Mechanisms of Action of Carbamazepine and Its Derivatives, Oxcarbazepine, BIA 2-093, and BIA 2-024
Ambrósio, A. F., Soares-da-Silva, P., Carvalho, C. M., & Carvalho, A. P. (2002) · Neurochemical Research · doi:10.1023/a:1014814924965 · Cited by 293
Sultan, A., Gaskell, H., Derry, S., & Moore, R. A. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-29 · Cited by 291
The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy
Sindrup, S. H., Bjerre, U., Dejgaard, A., Brøsen, K., Aaes-Jørgensen, T., & Gram, L. F. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.183 · Cited by 284
Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy
Greene, D. A., Arezzo, J. C., Brown, M. B., & the Zenarestat Study Group (1999) · Neurology · doi:10.1212/wnl.53.3.580 · Cited by 278
Rull, J. A., Quibrera, R., Gonz�lez-Mill�n, H., & Casta�eda, O. L. (1969) · Diabetologia · doi:10.1007/bf01212087 · Cited by 274
Ishii, H., Koya, D., & King, G. L. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050187 · Cited by 274
Diabetic Painful and Insensate Neuropathy: Pathogenesis and Potential Treatments
Obrosova, I. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.07.004 · Cited by 272
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
Schleicher, E. D., & Weigert, C. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07703.x · Cited by 271
Oxidative and nitrosative stress in brain mitochondria of diabetic rats
Mastrocola, R., Restivo, F., Vercellinatto, I., Danni, O., Brignardello, E., Aragno, M., & Boccuzzi, G. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06269 · Cited by 268
Role of Advanced Glycation End Products and Their Receptors in Development of Diabetic Neuropathy
WADA, R., & YAGIHASHI, S. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.067 · Cited by 263
Experimental diabetic neuropathy: an update
Sima, A. A. F., & Sugimoto, K. (1999) · Diabetologia · doi:10.1007/s001250051227 · Cited by 253
Topiramate vs placebo in painful diabetic neuropathy: Analgesic and metabolic effects
Raskin, P., Donofrio, P. D., Rosenthal, N. R., Hewitt, D. J., Jordan, D. M., Xiang, J., & Vinik, A. I. (2004) · Neurology · doi:10.1212/01.wnl.0000137341.89781.14 · Cited by 239
Hammack, J. E., Michalak, J. C., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., Soori, G. S., Tirona, M. T., Rowland, K. M., Stella, P. J., & Johnson, J. A. (2002) · Pain · doi:10.1016/s0304-3959(02)00047-7 · Cited by 231
Vranken, J. H., Dijkgraaf, M. G. W., Kruis, M. R., van der Vegt, M. H., Hollmann, M. W., & Heesen, M. (2008) · Pain · doi:10.1016/j.pain.2007.06.033 · Cited by 230
Hanna, M., O'Brien, C., & Wilson, M. C. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2007.12.010 · Cited by 225
Tölle, T., Freynhagen, R., Versavel, M., Trostmann, U., & Young, J. P. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2007.05.003 · Cited by 219
Hotta, N., Toyota, T., Matsuoka, K., Shigeta, Y., Kikkawa, R., Kaneko, T., Takahashi, A., Sugimura, K., Koike, Y., Ishii, J., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1776 · Cited by 217
Nerve Blood Flow and Oxygen Delivery In Normal, Diabetic, and Ischemic Neuropathy
Low, P. A., Lagerlund, T. D., & McManis, P. G. (1989) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60283-4 · Cited by 209
Mitogen-activated protein kinases as glucose transducers for diabetic complications
Tomlinson, D. R. (1999) · Diabetologia · doi:10.1007/s001250051439 · Cited by 193
Stracke, H., Gaus, W., Achenbach, U., Federlin, K., & Bretzel, R. G. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1065351 · Cited by 192
Young, R. J., Ewing, D. J., & Clarke, B. F. (1983) · Diabetes · doi:10.2337/diab.32.10.938 · Cited by 188
The Topiramate Diabetic Neuropathic Pain Study Group*, Thienel, U., Neto, W., Schwabe, S. K., & Vijapurkar, U. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00338.x · Cited by 187
Marshall, S., Garvey, W. T., & Traxinger, R. R. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1743436 · Cited by 184
Kumar, A., & Sharma, S. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.014 · Cited by 183
Early diabetic neuropathy: Triggers and mechanisms
Dobretsov, M. G., Romanovsky, D., & Stimers, J. R. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i2.175 · Cited by 183
Xia, P., Kramer, R. M., & King, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118117 · Cited by 181
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo‐controlled study
Dogra, S., Beydoun, S., Mazzola, J., Hopwood, M., & Wan, Y. (2005) · European Journal of Pain · doi:10.1016/j.ejpain.2004.11.006 · Cited by 179
Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway
Cameron, N., & Cotter, M. (2008) · Current Drug Targets · doi:10.2174/138945008783431718 · Cited by 179
Carbamazepine for acute and chronic pain in adults
Wiffen, P. J., Derry, S., Moore, R. A., & McQuay, H. J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005451 · Cited by 178
Toth, C., Mawani, S., Brady, S., Chan, C., Liu, C., Mehina, E., Garven, A., Bestard, J., & Korngut, L. (2012) · Pain · doi:10.1016/j.pain.2012.06.024 · Cited by 174
Yagihashi, S. (2001) · Brain · doi:10.1093/brain/124.12.2448 · Cited by 174
Haupt, E., Ledermann, H., & Köpcke, W. (2005) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp43071 · Cited by 173
Vinik, A. I., Bril, V., Kempler, P., Litchy, W. J., Tesfaye, S., Price, K. L., & Bastyr, E. J. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.08.001 · Cited by 171
The role of growth factors in diabetic peripheral neuropathy
Leinninger, G. M., Vincent, A. M., & Feldman, E. L. (2004) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2004.09105.x · Cited by 170
Sayeski, P. P., & Kudlow, J. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15237 · Cited by 169
Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy
Campbell, C. M., Kipnes, M. S., Stouch, B. C., Brady, K. L., Kelly, M., Schmidt, W. K., Petersen, K. L., Rowbotham, M. C., & Campbell, J. N. (2012) · Pain · doi:10.1016/j.pain.2012.04.014 · Cited by 165
Vinik, A. I., Tuchman, M., Safirstein, B., Corder, C., Kirby, L., Wilks, K., Quessy, S., Blum, D., Grainger, J., White, J., et al. (2007) · Pain · doi:10.1016/j.pain.2006.09.040 · Cited by 163
Effects of nabilone, a synthetic cannabinoid, on postoperative pain
Beaulieu, P. (2006) · Canadian Journal of Anesthesia/Journal canadien d'anesthésie · doi:10.1007/bf03022793 · Cited by 161
Dipeptidyl Peptidase‐4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Neumiller, J. J., Wood, L. D., & Campbell, R. K. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.5.463 · Cited by 157
A Benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy
Stracke, H. H. G., Lindemann, A., & Federlin, K. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211460 · Cited by 149
Inactivation of TNF-α ameliorates diabetic neuropathy in mice
Yamakawa, I., Kojima, H., Terashima, T., Katagi, M., Oi, J., Urabe, H., Sanada, M., Kawai, H., Chan, L., Yasuda, H., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00029.2011 · Cited by 146
Anjaneyulu, M., & Chopra, K. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00160-x · Cited by 142
Kajdasz, D. K., Iyengar, S., Desaiah, D., Bačkonja, M.-M., Farrar, J. T., Fishbain, D. A., Jensen, T. S., Rowbotham, M. C., Sang, C. N.-M., Ziegler, D., et al. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.12.002 · Cited by 141
Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy
Jack, M. M., & Wright, D. E. (2012) · Translational research · doi:10.1016/j.trsl.2011.12.004 · Cited by 141
Understanding the impact of painful diabetic neuropathy
Quattrini, C., & Tesfaye, S. H. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.360 · Cited by 140
Sindrup, S. H., Gram, L. F., Skjold, T., Grodum, E., Brøsen, K., & Beck‐Nielsen, H. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03836.x · Cited by 138
Recent advances in the management of diabetic distal symmetrical polyneuropathy
Tesfaye, S. H. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00083.x · Cited by 137
Koivisto, A., Hukkanen, M., Saarnilehto, M., Chapman, H., Kuokkanen, K., Wei, H., Viisanen, H., Åkerman, K. E. O., Lindstedt, K. A., & Pertovaara, A. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.10.006 · Cited by 137
Vrethem, M., Boivie, J., Arnqvist, H. J., Holmgren, H., Lindström, T., & Thorell, L. (1997) · Clinical Journal of Pain · doi:10.1097/00002508-199712000-00009 · Cited by 136
Management of diabetic complications: A chemical constituents based approach
Singh, R., Kaur, N., Kishore, L., & Gupta, G. K. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.08.051 · Cited by 134
Self-citationMechanisms of Disease: mitochondria as new therapeutic targets in diabetic neuropathy
Leinninger, G. M., Edwards, J. L., Lipshaw, M. J., & Feldman, E. L. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0320 · Cited by 134
Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms
Sindrup, S. H., Gram, L. F., Skjold, T., Frøland, A., & Beck-Nielsen, H. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.65 · Cited by 134
Kaeidi, A., Esmaeili‐Mahani, S., Sheibani, V., Abbasnejad, M., Rasoulian, B., Hajializadeh, Z., & Afrazi, S. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.04.038 · Cited by 130
Kress, H. G. (2010) · European Journal of Pain · doi:10.1016/j.ejpain.2010.06.017 · Cited by 130
CASELLINI, C. M., Barlow, P. M., Rice, A. L., Casey, M. A., Simmons, K. E., Pittenger, G. L., Bastyr, E. J., Wolka, A. M., & Vinik, A. I. (2007) · Diabetes Care · doi:10.2337/dc06-1699 · Cited by 129
Bril, V., Buchanan, R. A., & the Ranirestat Study Group* (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1447 · Cited by 128
Diabetic Complications: Current Challenges and Opportunities
Nickerson, H. D., & Dutta, S. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9388-1 · Cited by 125
Kuhad, A., & Chopra, K. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.013 · Cited by 123
Tschentke, T. M., Vry, J. D., Terlinden, R., et al. (2006) · Drugs of the Future · doi:10.1358/dof.2006.031.12.1047744 · Cited by 123
Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus
Logendra, S., Ribnicky, D., Yang, H., Poulev, A., Ma, J., Kennelly, E. J., & Raskin, I. (2006) · Phytochemistry · doi:10.1016/j.phytochem.2006.05.015 · Cited by 122
Kumar, A., Negi, G., & Sharma, S. S. (2012) · Biochimie · doi:10.1016/j.biochi.2012.01.023 · Cited by 116
The multifaceted therapeutic potential of benfotiamine
Balakumar, P., Rohilla, A., Krishan, P., Solairaj, P., & Thangathirupathi, A. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.02.008 · Cited by 114
Baydaş, G., Nedzvetsky, V. S., Nerush, P. A., Кириченко, С. В., & Yoldaş, T. K. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00561-7 · Cited by 114
Sima, A. A. F., Prashar, A., Zhang, W. X., Chakrabarti, S., & Greene, D. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114585 · Cited by 108
Fox, A., Gentry, C., Patel, S., Kesingland, A., & Bevan, S. (2003) · Pain · doi:10.1016/s0304-3959(03)00253-7 · Cited by 108
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
Ouardouz, M., Coderre, E., Basak, A., Chen, A. A., Zamponi, G. W., Hameed, S., Rehak, R., Yin, X., Trapp, B. D., & Stys, P. K. (2009) · Annals of Neurology · doi:10.1002/ana.21533 · Cited by 108
Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors
Ouardouz, M., Coderre, E., Zamponi, G. W., Hameed, S., Yin, X., Trapp, B. D., & Stys, P. K. (2009) · Annals of Neurology · doi:10.1002/ana.21539 · Cited by 107
Stavniichuk, R., Drel, V. R., Shevalye, H., Maksimchyk, Y., Kuchmerovska, T. M., Nadler, J. L., & Obrosova, I. G. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.04.002 · Cited by 106
Li, F., Obrosova, I. G., Abatan, O. I., Tian, D., Larkin, D. D., Stuenkel, E. L., & Stevens, M. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00168.2004 · Cited by 105
Gandhi, R. A., Marques, J. L. B., Selvarajah, D., Emery, C., & Tesfaye, S. H. (2010) · Diabetes Care · doi:10.2337/dc09-2314 · Cited by 105
Tapentadol hydrochloride. Analgesic, Mu-opioid receptor agonist, noradrenaline reuptake inhibitor
Tzschentke, T., Vry, J. D., Terlinden, R., Hennies, H. ‐., Lange, C., Straßburger, W., Haurand, M., Kolb, J., Schneider, J., Buschmann, H., et al. (2006) · Drugs of the Future · Cited by 105
Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice
Wang, L., Chopp, M., Szalad, A., Liu, Z., Bolz, M., Ãlvarez, F. M., Lu, M., Zhang, L., Cui, Y., Zhang, R. L., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.039 · Cited by 103
Cooper, M. E., Thallas, V., Forbes, J. M., Scalbert, E., Sastra, S. A., Darby, I. A., & Soulis, T. (2000) · Diabetologia · doi:10.1007/s001250051355 · Cited by 102
Cameron, N. E., Leonard, M., Ross, I. S., & Whiting, P. H. (1986) · Diabetologia · doi:10.1007/bf02427088 · Cited by 102
Potential new treatments for type 2 diabetes
Bailey, C. J. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01506-6 · Cited by 102
Srivastava, A. K. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.9.1.85 · Cited by 101
Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy
Ziegler, D., Hídvégi, T., Владимировна, Г. И., Bongardt, S., Freynhagen, R., Sen, D. L., Sommerville, K. W., & on behalf of the Lacosamide SP743 Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1578 · Cited by 100
Tiwari, V., Kuhad, A., & Chopra, K. (2011) · Phytotherapy Research · doi:10.1002/ptr.3440 · Cited by 99
Smith, A. G., & Singleton, J. R. (2012) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000411568.34085.3e · Cited by 95
Lee, B., Shi, L., Kassel, D. B., Asakawa, T., Takeuchi, K., & Christopher, R. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.047 · Cited by 93
Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study
Beydoun, A. A., Shaibani, A. I., Hopwood, M. B., & Wan, Y. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00631.x · Cited by 92
Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain
Kuhad, A., Sharma, S., & Chopra, K. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2007.10.008 · Cited by 91
Rowbotham, M. C., Duan, R. W., Thomas, J. W., Nothaft, W., & Bačkonja, M.-M. (2009) · Pain · doi:10.1016/j.pain.2009.06.013 · Cited by 91
Askwith, T., Zeng, W., Eggo, M. C., & Stevens, M. J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00287.2009 · Cited by 90
Rugini, E., Mencuccini, M., Biasi, R., & Altamura, M. M. (2005) · Springer eBooks · doi:10.1007/1-4020-2985-3_27 · Cited by 89
Vareniuk, І., Pavlov, I. A., & Obrosova, I. G. (2008) · Diabetologia · doi:10.1007/s00125-008-1136-3 · Cited by 88
Cameron, N. E., & Cotter, M. A. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.307 · Cited by 86
Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats
Li, F., Abatan, O. I., Kim, H. S., Burnett, D., Larkin, D. D., Obrosova, I. G., & Stevens, M. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.012 · Cited by 85
Inkster, M. E., Cotter, M. A., & Cameron, N. E. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.029 · Cited by 84
Negi, G., Kumar, A., Kaundal, R. K., Gulati, A., & Sharma, S. S. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.018 · Cited by 84
Sun, W., Miao, B., Wang, X., Duan, J.-H., Ye, X., Han, W., Wang, W., Luo, C., & Hu, S.-J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039647 · Cited by 83
Efficacy of Tapentadol ER for Managing Moderate to Severe Chronic Pain
Afilalo, M., & Morlion, B. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/27 · Cited by 83
Yücel, A., Ozyalcin, S., Talu, G. K., Kiziltan, E., Yücel, B., Andersen, O. K., Arendt‐Nielsen, L., & Dişçi, R. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2004.09.009 · Cited by 82
Coppey, L. J., Gellett, J. S., Davidson, E. P., Dunlap, J. A., & Yorek, M. A. (2001) · Journal of Diabetes Research · doi:10.1080/15604280212525 · Cited by 79
Ulugöl, A., Karadağ, Ç. H., Tamer, M., Firat, Z., Aslantaş, A., & Dökmeci, İ. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00491-3 · Cited by 77
Sesamol Suppresses Neuro-Inflammatory Cascade in Experimental Model of Diabetic Neuropathy
Chopra, K., Tiwari, V., Arora, V. K., & Kuhad, A. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.01.006 · Cited by 76
The role of polyol pathway in high glucose-induced endothelial cell damages
Oyama, T., Miyashita, Y., Watanabe, H., & Shirai, K. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.02.010 · Cited by 74
Shi, T.-J. S., Zhang, M., Zeberg, H., Nilsson, J., Grünler, J., Liu, S.-X., Xiang, Q., Persson, J., Fried, K., Catrina, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220794110 · Cited by 74
Painful Diabetic Neuropathy: A Management-Centered Review
Huizinga, M. M., & Peltier, A. (2007) · Clinical Diabetes · doi:10.2337/diaclin.25.1.6 · Cited by 74
Rutkove, S. B., & McIlduff (2011) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s11325 · Cited by 72
Roberts, R. E., & McLean, W. G. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00062-0 · Cited by 70
Zhang, Y. P., Eber, A. E., Yuan, Y., Yang, Z., Rodriguez, Y. F., Levitt, R. C., Takács, P., & Candiotti, K. A. (2013) · Anesthesiology · doi:10.1097/aln.0b013e3182829b7b · Cited by 69
Diosgenin from Dioscorea nipponica Ameliorates Diabetic Neuropathy by Inducing Nerve Growth Factor
Kang, T. H., Moon, E., Hong, B. N., Choi, S. Z., Son, M., Park, J. H., & Kim, S. Y. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1493 · Cited by 69
Balakumar, P., Arora, M. K., Ganti, S. S., Reddy, J., & Singh, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.02.002 · Cited by 65
Boyd, A. L., CASELLINI, C. M., Vinik, E. J., & Vinik, A. I. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500326 · Cited by 65
Inhibition of advanced glycation end-product formation on eye lens protein by rutin
Muthenna, P., Akileshwari, C., Saraswat, M., & Reddy, G. B. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004077 · Cited by 63
Wang, Z. Q., Ribnicky, D., Zhang, X. H., Zuberi, A. R., Raskin, I., Yu, Y., & Cefalu, W. T. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.11.015 · Cited by 62
Borghini, I., Ania‐Lahuerta, A., Regazzi, R., Ferrari, G., Gjinovci, A., Wollheim, C. B., & Pralong, W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62020686.x · Cited by 61
The NK1‐receptor antagonist TKA731 in painful diabetic neuropathy: A randomised, controlled trial
Sindrup, S. H., Graf, A., & Sfikas, N. (2005) · European Journal of Pain · doi:10.1016/j.ejpain.2005.08.001 · Cited by 59
Sharma, S. S., Kumar, A., Arora, M., & Kaundal, R. K. (2009) · Free Radical Research · doi:10.1080/10715760902801509 · Cited by 58
Wu, S., & Ren, J. T. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.022 · Cited by 57
Bianchi, R., Cervellini, I., Porretta‐Serapiglia, C., Oggioni, N., Burkey, B. F., Ghezzi, P., Cavaletti, G., & Lauria, G. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.181529 · Cited by 56
Protection of Trigonelline on Experimental Diabetic Peripheral Neuropathy
Zhou, J., & Zhou, S.-W. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/164219 · Cited by 54
Watcho, P., Stavniichuk, R., Ribnicky, D., Raskin, I., & Obrosova, I. G. (2010) · Mediators of Inflammation · doi:10.1155/2010/268547 · Cited by 53
Matsumoto, T., Ono, Y., Kurono, M., Kuromiya, A., Nakamura, K., & Bril, V. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08061fp · Cited by 53
Rowbotham, M. C., Arslanian, A., Nothaft, W., Duan, R. W., Best, A. E., Pritchett, Y., Zhou, Q., & Stacey, B. R. (2012) · Pain · doi:10.1016/j.pain.2012.01.009 · Cited by 52
Kawai, T., Takei, I., Tokui, M., Funae, O., Miyamoto, K., Tabata, M., Hirata, T., Saruta, T., Shimada, A., & Itoh, H. (2009) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.10.005 · Cited by 52
Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain
Peppin, J. F., Majors, Webster, L. R., Simpson, Tobias, J. K., & Vanhove (2011) · Journal of Pain Research · doi:10.2147/jpr.s22954 · Cited by 49
Raccah, D., Coste, T. C., Cameron, N. E., Dufayet, D., Vague, P., & Hohman, T. C. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00093-7 · Cited by 48
Morani, A. S., Bodhankar, S. L., Mohan, V., et al. (2012) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(12)60064-9 · Cited by 47
Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic mice
Wang, L., Chopp, M., Szalad, A., Liu, Z., Lü, M., Zhang, L., Zhang, J., Zhang, R. L., Morris, D., & Zhang, Z. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.002 · Cited by 44
Somfai, G. M., Knippel, B., Ruzicska, É., Stadler, K., Tóth, M., Salacz, G., Magyar, K., & Somogyi, A. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.009 · Cited by 44
Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibers
Ichikawa, K., Koyama, N., Kiguchi, S., et al. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01007-x · Cited by 42
Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy
Kiguchi, S., Imamura, T., Ichikawa, K., et al. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.03950.x · Cited by 41
Landry, M., Bouali‐Benazzouz, R., André, C., Shi, T. J., Léger, C., Nagy, F., & Hökfelt, T. G. M. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21109 · Cited by 40
Clinical approach to the treatment of painful diabetic neuropathy
Hovaguimian, A., & Gibbons, C. H. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810391900 · Cited by 40
Askwith, T., Zeng, W., Eggo, M. C., & Stevens, M. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.010 · Cited by 40
Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat
Kuzumoto, Y., Kusunoki, S., Kato, N., Kihara, M., & Low, P. A. (2006) · Diabetologia · doi:10.1007/s00125-006-0400-7 · Cited by 38
Kim, N., Kim, S.-H., Kim, Y., Kim, J.-K., Nam, M., Rhim, H., Yoon, S. K., Choi, S., Son, M., Kim, S. Y., et al. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.05.032 · Cited by 37
Obrosova (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.597 · Cited by 36
Cameron, N. E., & Cotter, M. A. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb13389.x · Cited by 35
Davidson, E. P., Coppey, L. J., Dake, B. L., & Yorek, M. A. (2011) · Experimental Diabetes Research · doi:10.1155/2011/810469 · Cited by 34
Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy
Bhatt, L. K., & Veeranjaneyulu, A. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0243-3 · Cited by 33
Kheterpal, I., Coleman, L., Ku, G., Wang, Z. Q., Ribnicky, D., & Cefalu, W. T. (2010) · Phytotherapy Research · doi:10.1002/ptr.3093 · Cited by 32
Coppey, L. J., Davidson, E. P., Lu, B., Gerard, C. J., & Yorek, M. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.008 · Cited by 31
Ischemic heart disease and congestive heart failure in diabetic patients
Tang, W. H. W., Maroo, A. P., & Young, J. B. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.008 · Cited by 31
The effects of galanin on neuropathic pain in streptozotocin-induced diabetic rats
Xu, X., Liu, Z., Liu, H., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.01.011 · Cited by 28
Webster, L. R., Peppin, J. F., Murphy, Tobias, J. K., & Vanhove (2012) · Journal of Pain Research · doi:10.2147/jpr.s25272 · Cited by 28
Zotova, E. G., Christ, G. J., Zhao, W., Tar, M., Kuppam, S. D., & Arezzo, J. C. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.10.001 · Cited by 23
Li, L. (2010) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-10-22 · Cited by 23
Liu, W. J., Jin, H. Y., Park, J. H., Baek, H. S., & Park, T. S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.004 · Cited by 19
Kihara, M., Mitsui, Y., Shioyama, M., Hasegawa, T., Takahashi, M., Takakura, S., Minoura, K., & Kawamura, I. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02052-3 · Cited by 17
Saxagliptin: A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes
Lam, S., & Saad, M. (2010) · Cardiology in Review · doi:10.1097/crd.0b013e3181daad5f · Cited by 9
Cited by
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Sandireddy, R., Yerra, V. G., Areti, A., Komirishetty, P., & Kumar, A. (2014) · International Journal of Endocrinology · doi:10.1155/2014/674987 · Cited by 364
Updates in diabetic peripheral neuropathy
Juster-Switlyk, K., & Smith, A. G. (2016) · F1000Research · doi:10.12688/f1000research.7898.1 · Cited by 288
Miric, D. J., Kisic, B. M., Filipovic-Danic, S., Grbic, R., Dragojevic, I., Miric, M. B., & Puhalo-Sladoje, D. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4370490 · Cited by 70
Metadata
- Authors
- Singh, R., Kishore, L., & Kaur, N.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 80
- Pages
- 21-35
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2039718439
- Cited by
- 400
- References
- 196
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.